Eli Lilly, Resilience Announce $750M Investment to Increase Diabetes, Obesity Meds Production
The deal gives Lilly access to BPL-003, a phase 3 intranasal depression therapy that Jefferies says could reach $1 billion to $2 billion in peak sales.
7 Articles
7 Articles
The factory that Eli Lilly wants to build in Katwijk costs around three billion dollars and is one of the largest foreign investments in the Netherlands in recent years. Residents are gathering objections against the plans being pushed by the cabinet, the province, and the municipality.
Eli Lilly, Resilience announce $750M investment to increase diabetes, obesity meds production
Pharmaceutical giant Eli Lilly and biomanufacturer Resilience are expanding their partnership with a $750 million investment to increase production of diabetes and obesity injectables.
Lilly, Resilience to invest $750 million in US drug manufacturing expansion
July 30 (Reuters) - Drugmaker Eli Lilly and privately held contract manufacturer Resilience will invest $750 million to expand pharmaceutical manufacturing capacity in the U.S. and strengthen the domestic medicine supply chain, Resilience said on Thu...
Resilience, Lilly invest $750M in pharma, KwikPen manufacturing
[Image courtesy of Resilience/Lilly]Resilience announced today that it expanded its strategic partnership with Eli Lilly (NYSE:LLY) to increase medicine production in the U.S. The Cincinnati-based CDMO and the pharmaceutical giant first struck a partnership in 2023. Now, with $750 million invested, the companies are expanding Resilience’s advanced pharmaceutical manufacturing operations in Ohio. Now, Resilience’s production in that region includ…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
